These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 23849098)

  • 1. Diffusion-weighted imaging and positron emission tomography in various cytological subtypes of primary lung adenocarcinoma.
    Tanaka R; Nakazato Y; Horikoshi H; Tsuchida S; Yoshida T; Nakazato Y; Tachibana K; Kondo H; Goya T
    Clin Imaging; 2013; 37(5):876-83. PubMed ID: 23849098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
    Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
    Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion-weighted magnetic resonance imaging in preoperative assessment of non-small cell lung cancer.
    Nomori H; Cong Y; Abe M; Sugimura H; Kato Y
    J Thorac Cardiovasc Surg; 2015 Apr; 149(4):991-6. PubMed ID: 25686657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDG-PET/CT and diffusion-weighted imaging for resected lung cancer: correlation of maximum standardized uptake value and apparent diffusion coefficient value with prognostic factors.
    Usuda K; Funasaki A; Sekimura A; Motono N; Matoba M; Doai M; Yamada S; Ueda Y; Uramoto H
    Med Oncol; 2018 Apr; 35(5):66. PubMed ID: 29633024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathologic characterization of lung adenocarcinoma in relation to fluorine-18-fluorodeoxyglucose uptake on positron emission tomography.
    Domen H; Hida Y; Okamoto S; Hatanaka KC; Hatanaka Y; Kaga K; Tamaki N; Hirano S; Matsuno Y
    Jpn J Clin Oncol; 2013 Sep; 43(9):874-82. PubMed ID: 23911772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is diffusion-weighted magnetic resonance imaging superior to positron emission tomography with fludeoxyglucose F 18 in imaging non-small cell lung cancer?
    Ohba Y; Nomori H; Mori T; Ikeda K; Shibata H; Kobayashi H; Shiraishi S; Katahira K
    J Thorac Cardiovasc Surg; 2009 Aug; 138(2):439-45. PubMed ID: 19619793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing diffusion-weighted imaging and positron emission tomography for pulmonary nodules measuring from 1 to 3 cm in size.
    Nomori H; Cong Y; Sugimura H; Kato Y
    Surg Today; 2015 Dec; 45(12):1535-41. PubMed ID: 25673032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between apparent diffusion coefficients on diffusion-weighted MRI and standardized uptake value on FDG-PET/CT in pancreatic adenocarcinoma.
    Sakane M; Tatsumi M; Kim T; Hori M; Onishi H; Nakamoto A; Eguchi H; Nagano H; Wakasa K; Hatazawa J; Tomiyama N
    Acta Radiol; 2015 Sep; 56(9):1034-41. PubMed ID: 25267921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histological subtypes of lung adenocarcinoma have differential ¹⁸F-fluorodeoxyglucose uptakes on the positron emission tomography/computed tomography scan.
    Chiu CH; Yeh YC; Lin KH; Wu YC; Lee YC; Chou TY; Tsai CM
    J Thorac Oncol; 2011 Oct; 6(10):1697-703. PubMed ID: 21869716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion-weighted imaging (DWI) signal intensity and distribution represent the amount of cancer cells and their distribution in primary lung cancer.
    Usuda K; Zhao XT; Sagawa M; Aikawa H; Ueno M; Tanaka M; Machida Y; Matoba M; Ueda Y; Sakuma T
    Clin Imaging; 2013; 37(2):265-72. PubMed ID: 23465978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic phenotype of stage IV lung adenocarcinoma: relationship with epidermal growth factor receptor mutation.
    Lee EY; Khong PL; Lee VH; Qian W; Yu X; Wong MP
    Clin Nucl Med; 2015 Mar; 40(3):e190-5. PubMed ID: 25608155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Close association of IASLC/ATS/ERS lung adenocarcinoma subtypes with glucose-uptake in positron emission tomography.
    Nakamura H; Saji H; Shinmyo T; Tagaya R; Kurimoto N; Koizumi H; Takagi M
    Lung Cancer; 2015 Jan; 87(1):28-33. PubMed ID: 25481488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hybrid [¹⁸F]-FDG PET/MRI including non-Gaussian diffusion-weighted imaging (DWI): preliminary results in non-small cell lung cancer (NSCLC).
    Heusch P; Köhler J; Wittsack HJ; Heusner TA; Buchbender C; Poeppel TD; Nensa F; Wetter A; Gauler T; Hartung V; Lanzman RS
    Eur J Radiol; 2013 Nov; 82(11):2055-60. PubMed ID: 23830904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion-weighted magnetic resonance imaging in differentiating the invasiveness of small lung adenocarcinoma.
    Tanaka R; Horikoshi H; Yoshida T; Nakazato Y; Seki E; Goya T
    Acta Radiol; 2011 Sep; 52(7):750-5. PubMed ID: 21565888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathology of lung adenocarcinoma based on new IASLC/ATS/ERS classification: prognostic stratification with functional and metabolic imaging biomarkers.
    Lee HY; Jeong JY; Lee KS; Yi CA; Kim BT; Kang H; Kwon OJ; Shim YM; Han J
    J Magn Reson Imaging; 2013 Oct; 38(4):905-13. PubMed ID: 23908132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting pleural invasion using HRCT and 18F-FDG PET/CT in lung adenocarcinoma with pleural contact.
    Tanaka T; Shinya T; Sato S; Mitsuhashi T; Ichimura K; Soh J; Toyooka S; Kaji M; Miyoshi S; Kanazawa S
    Ann Nucl Med; 2015 Nov; 29(9):757-65. PubMed ID: 26142739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion-weighted magnetic resonance imaging for diagnosing malignant pulmonary nodules/masses: comparison with positron emission tomography.
    Mori T; Nomori H; Ikeda K; Kawanaka K; Shiraishi S; Katahira K; Yamashita Y
    J Thorac Oncol; 2008 Apr; 3(4):358-64. PubMed ID: 18379353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations among bronchioloalveolar carcinoma components, positron emission tomographic and computed tomographic findings, and malignant behavior in small lung adenocarcinomas.
    Okada M; Tauchi S; Iwanaga K; Mimura T; Kitamura Y; Watanabe H; Adachi S; Sakuma T; Ohbayashi C
    J Thorac Cardiovasc Surg; 2007 Jun; 133(6):1448-54. PubMed ID: 17532938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positron emission tomography for predicting recurrence in stage I lung adenocarcinoma: standardized uptake value corrected by mean liver standardized uptake value.
    Shiono S; Abiko M; Okazaki T; Chiba M; Yabuki H; Sato T
    Eur J Cardiothorac Surg; 2011 Nov; 40(5):1165-9. PubMed ID: 21507671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solitary pulmonary nodular lung adenocarcinoma: correlation of histopathologic scoring and patient survival with imaging biomarkers.
    Lee HY; Jeong JY; Lee KS; Kim HJ; Han J; Kim BT; Kim J; Shim YM; Kim JH; Song I
    Radiology; 2012 Sep; 264(3):884-93. PubMed ID: 22829686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.